Pinnacle Clinical Research Acquires Jubilee Clinical Research

LongueVue Capital Invests in Pinnacle Clinical Research

November 16, 2022

Healthcare Services

LongueVue Capital, a New Orleans-based private equity firm, completed a growth investment in Pinnacle Clinical Research, a San Antonio-based multi-location clinical trial site network specializing in complex therapeutic areas including hepatology (NAFLD/NASH). The capital from LVC is intended to support Pinnacle’s organic and inorganic growth, expand clinical trial capacity, and enhance operational capabilities across its Texas sites.

Pinnacle Clinical Research (LongueVue Capital) Combines with South Texas Research Institute

January 10, 2023

Healthcare Services

Pinnacle Clinical Research, a LongueVue Capital portfolio company, has completed a combination with South Texas Research Institute (STRI). The deal expands Pinnacle's clinical site network to six dedicated locations, strengthens recruitment capabilities (notably for NASH/NAFLD trials) and increases geographic reach into the Rio Grande Valley.

Summit Clinical Research (with Pinnacle) Acquires Houston Research Institute

February 28, 2025

Healthcare Services

LongueVue Capital portfolio company Summit Clinical Research, in partnership with Pinnacle Clinical Research, completed a strategic investment in Houston Research Institute (HRI) to expand Summit's metabolic/hepatology clinical research capabilities. The transaction brings HRI's scientific expertise into Summit/Pinnacle's site network and is accompanied by leadership additions — Dr. Mazen Noureddin named Co-Chairman (and Chief Scientific Officer), Dr. Naim Alkhouri as Chief Academic Officer, and Brandon Early as President.

Pinnacle Clinical Research Adds Five Sites to Network (KMC, CRCNJ, Bellaire, Palmetto, DRI)

June 18, 2024

Healthcare Services

Pinnacle Clinical Research, a portfolio company of LongueVue Capital, has acquired or partnered with five clinical research sites — Kerwin Medical Center, The Cognitive and Research Center of New Jersey, Bellaire Clinical Research, Palmetto Clinical Research – Low Country, and Dallas Research Institute — expanding Pinnacle’s network to 12 U.S. sites. The transactions broaden Pinnacle’s geographic footprint and add CNS/Alzheimer’s and metabolic disease capabilities, strengthening the platform’s ability to serve sponsors and underrepresented patient populations.

LongueVue Capital Invests in Summit Clinical Research

October 26, 2022

Healthcare Services

LongueVue Capital completed a growth investment in Summit Clinical Research, an integrated research organization (IRO) headquartered in San Antonio, Texas. The investment will provide financial and human capital to accelerate Summit's growth and expand its clinical trial site network and capabilities, particularly in hepatology and NASH research.

Velocity Clinical Research Acquires Meridian Clinical Research

December 15, 2022

Healthcare Services

Velocity Clinical Research, a GHO-backed integrated research site organization, has acquired Meridian Clinical Research for an undisclosed amount. The deal creates the largest dedicated clinical research site organization globally (about 80 sites), expands Velocity's U.S. footprint to 25 states and adds Meridian's network of 35+ sites and experienced investigators and staff.